Sort
82,697 grants matching “vaccine development”
Understanding reservoir effects and curative potential of a CD3/CCR5 bispecific antibody in infant macaques
$788,984Dennis J Hartigan-O'Connor · University Of California At Davis · R01 · FY2025 · AI
Optimizing Adjuvants and Needle Free Delivery Methods for Oral HIV Vaccination
$788,873Rama Rao Amara · Emory University · R01 · FY2020 · DE
Administrative Core
$788,841David Mitchell Smith · University Of California, San Diego · P30 · FY2019 · AI
Post-exposure immunotherapy for ricin exposure
$788,841Miles Burke Brennan · Zabbio, Inc. · R44 · FY2021 · AI
CRYPTOCOCCUS NEOFORMANS--A MODEL FOR PATHOGENIC FUNGI
$788,829Duke University · P01 · FY2000 · AI
Characteristics and protective efficacy of human antibodies against M. tuberculosis
$788,818Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2019 · AI
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$788,776Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2024 · AI
Impact of the Intestinal Microbiome on HIV/SIV Vaccines
$788,705Megan T Baldridge · Washington University · R01 · FY2020 · OD
Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models
$788,659Matthias Johannes Schnell · Thomas Jefferson University · R01 · FY2025 · AI
COVID-19, Inflammation and HPA axis activity, and Risk for Psychopathology in Youth
$788,640Nadine M. Melhem · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · MH
Maternal Immunization and Determinants of Infant Immunity
$788,568Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2025 · AI
Biomedical Imaging
$788,503Benes L Trus · Center For Information Technology · ZIA · FY2018 · CT
Defining functional humoral correlates of immunity to guide vaccine design
$788,464Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2024 · AI
A vaccine for genital herpes that achieves sterilizing immunity
$788,448Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2022 · AI
Defining functional humoral correlates of immunity to guide vaccine design
$788,432Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2025 · AI
The Environmental Determinants of Diabetes in Youth: Washington Clinical Center
$788,400William A. Hagopian · Pacific Northwest Research Institute · U01 · FY2008 · DK
Preventing TB with intravenous BCG in SIV-infected macaques
$788,364Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models
$788,347Matthias Johannes Schnell · Thomas Jefferson University · R01 · FY2023 · AI
Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models
$788,347Matthias Johannes Schnell · Thomas Jefferson University · R01 · FY2024 · AI
A Multidisciplinary Approach to Understanding TB Latency and Reactivation
$788,317Petros C Karakousis · Johns Hopkins University · R01 · FY2011 · HL
MAb Passive Vaccination against Acinetobacter baumannii
$788,308Brad J Spellberg · University Of Southern California · R01 · FY2024 · AI
Institute of Human Virology Clinical Trials Unit
$788,268Charles Edward Davis · University Of Maryland Baltimore · UM1 · FY2012 · AI
Efficacy of Oral CMV/SIV Vectors
$788,255Louis J. Picker · Oregon Health & Science University · R01 · FY2012 · DE
MECHANISMS REGULATING AIRWAY EOSINOPHILIC INFLAMMATION
$788,238University Of Texas Medical Br Galveston · P01 · FY2001 · AI
Breaching the species barrier: Towards an immunocompetent HBV-susceptible mouse model
$788,208Charles M. Rice · Rockefeller University · R01 · FY2024 · AI